Neil Harris Cohen

CIK: 0001840006

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (22.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (77.8%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CMMB

Chemomab Therapeutics Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

CMMB
Chemomab Therapeutics Ltd.
Aug 28, 2026
Sale(S)
Direct
1K shares at avg. $2.80$3K
CMMB
Chemomab Therapeutics Ltd.
Aug 27, 2026
Sale(S)
Direct
1.3K shares at avg. $2.85$4K
CMMB
Chemomab Therapeutics Ltd.
Mar 16, 2026
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
5.2K shares-
CMMB
Chemomab Therapeutics Ltd.
Mar 16, 2025
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
3.8K shares-
CMMB
Chemomab Therapeutics Ltd.
Mar 18, 2024
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
2.5K shares-
CMMB
Chemomab Therapeutics Ltd.
Mar 21, 2023
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
1.7K shares-
CMMB
Chemomab Therapeutics Ltd.
Mar 7, 2022
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
1.7K shares-
CMMB
Chemomab Therapeutics Ltd.
Apr 19, 2021
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
3K shares-
CMMB
Chemomab Therapeutics Ltd.
Jul 16, 2020
Award(A)
Stock option (right to buy American Depositary Shares)
Direct
172 shares-

		Type	Shares	Price		Ownership
Aug 28, 2026	CMMB Chemomab Therapeutics Ltd.	Sale(S)	1,000	$2.80	$2,800	Direct
Aug 27, 2026	CMMB Chemomab Therapeutics Ltd.	Sale(S)	1,304	$2.85	$3,716	Direct
Mar 16, 2026	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	5,172	-	-	Direct
Mar 16, 2025	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	3,821	-	-	Direct
Mar 18, 2024	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	2,520	-	-	Direct
Mar 21, 2023	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	1,714	-	-	Direct
Mar 7, 2022	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	1,705	-	-	Direct
Apr 19, 2021	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	2,971	-	-	Direct
Jul 16, 2020	CMMB Chemomab Therapeutics Ltd.	Award(A) Stock option (right to buy American Depositary Shares)	172	-	-	Direct

1-9 of 9 transactions

About Cohen Neil Harris

Cohen Neil Harris (SEC CIK 0001840006) files insider reports with the SEC as Director of Chemomab Therapeutics Ltd. (CMMB).

Signal8 holds 2 ownership filings by Cohen Neil Harris (1 Form 3, 1 Form 4), filed between Apr 10, 2026 and Sep 1, 2026. Those filings report 9 transactions, from Jul 16, 2020 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cohen Neil Harris's filings is in CAMBRIDGE, MA.

Recent filings by Cohen Neil Harris

Aug 28, 2026: Open-market sale of CMMB shares (Form 4, code S).
Aug 27, 2026: Open-market sale of CMMB shares (Form 4, code S).
Mar 16, 2026: Grant or award of CMMB derivative securities (Form 4, code A).
Mar 16, 2025: Grant or award of CMMB derivative securities (Form 4, code A).
Mar 18, 2024: Grant or award of CMMB derivative securities (Form 4, code A).

Other insiders filing for Chemomab Therapeutics Ltd. (CMMB)

Melincoff Gwen A, Director
Mor George Adi, Chief Executive Officer
Darvish Nissim, Director
Moses Alan Charles, Director
Fatal Sigal, Chief Financial Officer
Lawler John, Chief Development Officer

How to read Form 4 transaction codes